Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 15451 - 15475 of 16073 in total

Lactobacillus crispatus strain CTV-05

Investigational

Tivanisiran

Tivanisiran is under investigation in clinical trial NCT03108664 (HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED)).
Investigational

Lapuleucel-t

Investigational

Redasemtide

Redasemtide is under investigation in clinical trial NCT05953480 (A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke).
Investigational

Baltaleucel-T

Investigational

EMI-137

EMI-137 is under investigation in clinical trial NCT03360461 (EMI-137 in Laparoscopic Colonic Resections).
Investigational

Atexakin alfa

Atexakin alfa is under investigation in clinical trial NCT05435742 (SON-080 in Patients With Persistent Chemotherapy-induced Peripheral Neuropathy (CIPN)).
Investigational

Lixudebart

Lixudebart, an investigational first-in-class monoclonal antibody, aims to reverse fibrosis.
Investigational

Bos taurus colostrum

Investigational

Ecklonia cava

Investigational

Stapuldencel

Investigational

Pseudomonas aeruginosa

Investigational

Cancer/testis antigen 1

Investigational

Human placenta hydrolysate

Investigational

Interleukin-12 human recombinant

Investigational

Bemiltenase alfa

Investigational

ION356

Investigational

BV2

Experimental

4-[(3-BROMO-4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE

Experimental

Carbuterol

Experimental

CRA_1144

Experimental

N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide

Experimental

N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine

Experimental

N-(3-AMINOPROPYL)-2-NITROBENZENAMINE

Experimental

1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea

Experimental
Displaying drugs 15451 - 15475 of 16073 in total